Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Long-Term Debt Repayments (2024 - 2025)

Health Catalyst's Long-Term Debt Repayments history spans 2 years, with the latest figure at $407000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 30.03% year-over-year to $407000.0; the TTM value through Dec 2025 reached $232.3 million, up 24122.31%, while the annual FY2025 figure was $232.3 million, 24122.31% up from the prior year.
  • Long-Term Debt Repayments reached $407000.0 in Q4 2025 per HCAT's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $230.4 million in Q2 2025 to a low of $313000.0 in Q4 2024.